INS and type 2 diabetes mellitus: This hormone counteracts hypoglycemia and opposes insulin actions by stimulating hepatic glucose synthesis and mobilization, thereby increasing blood glucose concentrations [3]; a large body of evidence shows that hyperglucagonemia is essential to the maintenance of increased rates of hepatic glucose output in type 2 diabetes [4], [5].